Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2015 1
2016 1
2017 2
2018 2
2019 1
2020 6
2021 5
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Nipah virus disease: A rare and intractable disease.
Banerjee S, Gupta N, Kodan P, Mittal A, Ray Y, Nischal N, Soneja M, Biswas A, Wig N. Banerjee S, et al. Among authors: ray y. Intractable Rare Dis Res. 2019 Feb;8(1):1-8. doi: 10.5582/irdr.2018.01130. Intractable Rare Dis Res. 2019. PMID: 30881850 Free PMC article. Review.
Collateral damage due to COVID-19.
Fazal F, Gupta N, Khot W, Ray Y. Fazal F, et al. Among authors: ray y. Trop Doct. 2021 Jan;51(1):126-127. doi: 10.1177/0049475520942387. Epub 2020 Jul 26. Trop Doct. 2021. PMID: 32715939 No abstract available.
Post COVID sequelae among COVID-19 survivors: insights from the Indian National Clinical Registry for COVID-19.
Kumar G, Bhalla A, Mukherjee A, Turuk A, Talukdar A, Mukherjee S, Bhardwaj P, Menon GR, Sahu D, Misra P, Sharma LK, Mohindra R, S S, Suri V, Das H, Sarkar D, Ghosh S, Ghosh P, Dutta M, Chakraborty S, Kumar D, Gupta MK, Goel AD, Baruah TD, Kannauje PK, Shukla AK, Khambholja JR, Patel A, Shah N, Bhuniya S, Panigrahi MK, Mohapatra PR, Pathak A, Sharma A, John M, Kaur K, Nongpiur V, Pala S, Shivnitwar SK, Krishna BR, Dulhani N, Gupta B, Gupta J, Bhandari S, Agrawal A, Aggarwal HK, Jain D, Shah AD, Naik P, Panchal M, Anderpa M, Kikon N, Humtsoe CN, Sharma N, Vohra R, Patnaik L, Sahoo JP, Joshi R, Kokane A, Ray Y, Rajvansh K, Purohit HM, Shah NM, Madharia A, Dube S, Shrivastava N, Kataria S, Shameem M, Fatima N, Ghosh S, Hazra A, D H, Salgar VB, Algur S, M L KY, M PK, Panda S, Vishnu Vardhana Rao M, Bhargava B. Kumar G, et al. Among authors: ray y. BMJ Glob Health. 2023 Oct;8(10):e012245. doi: 10.1136/bmjgh-2023-012245. BMJ Glob Health. 2023. PMID: 37816536 Free PMC article.
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
Bandopadhyay P, D'Rozario R, Lahiri A, Sarif J, Ray Y, Paul SR, Roy R, Maiti R, Chaudhuri K, Bagchi S, Maiti A, Perwez MM, Sarkar BS, Roy D, Chakraborty R, Vasudevan JS, Sharma S, Biswas D, Maiti C, Saha B, Bhattacharya P, Pandey R, Chatterjee S, Paul S, Ganguly D. Bandopadhyay P, et al. Among authors: ray y. J Infect Dis. 2021 Aug 16;224(4):565-574. doi: 10.1093/infdis/jiab010. J Infect Dis. 2021. PMID: 34398242 Free PMC article. Clinical Trial.
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Ray Y, Paul SR, Bandopadhyay P, D'Rozario R, Sarif J, Raychaudhuri D, Bhowmik D, Lahiri A, Vasudevan JS, Maurya R, Kanakan A, Sharma S, Kumar M, Singh P, Roy R, Chaudhury K, Maiti R, Bagchi S, Maiti A, Perwez MM, Mondal A, Tewari A, Mandal S, Roy A, Saha M, Biswas D, Maiti C, Bhaduri R, Chakraborty S, Sarkar BS, Haldar A, Saha B, Sengupta S, Pandey R, Chatterjee S, Bhattacharya P, Paul S, Ganguly D. Ray Y, et al. Nat Commun. 2022 Jan 19;13(1):383. doi: 10.1038/s41467-022-28064-7. Nat Commun. 2022. PMID: 35046397 Free PMC article. Clinical Trial.
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.
Park H, Tarpey T, Liu M, Goldfeld K, Wu Y, Wu D, Li Y, Zhang J, Ganguly D, Ray Y, Paul SR, Bhattacharya P, Belov A, Huang Y, Villa C, Forshee R, Verdun NC, Yoon HA, Agarwal A, Simonovich VA, Scibona P, Burgos Pratx L, Belloso W, Avendaño-Solá C, Bar KJ, Duarte RF, Hsue PY, Luetkemeyer AF, Meyfroidt G, Nicola AM, Mukherjee A, Ortigoza MB, Pirofski LA, Rijnders BJA, Troxel A, Antman EM, Petkova E. Park H, et al. Among authors: ray y. JAMA Netw Open. 2022 Jan 4;5(1):e2147375. doi: 10.1001/jamanetworkopen.2021.47375. JAMA Netw Open. 2022. PMID: 35076698 Free PMC article.
Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.
Raychaudhuri D, Bandopadhyay P, D'Rozario R, Sarif J, Ray Y, Paul SR, Singh P, Chaudhuri K, Bhaduri R, Pandey R, Bhattacharya P, Sengupta S, Chatterjee S, Ganguly D. Raychaudhuri D, et al. Among authors: ray y. Mayo Clin Proc Innov Qual Outcomes. 2022 Dec;6(6):511-524. doi: 10.1016/j.mayocpiqo.2022.09.001. Epub 2022 Sep 14. Mayo Clin Proc Innov Qual Outcomes. 2022. PMID: 36117954 Free PMC article.
26 results